Chemokines as mediators of angiogenesis
- PMID: 17479186
- PMCID: PMC3353527
Chemokines as mediators of angiogenesis
Abstract
Chemokines were originally described as cytokines that mediate leukocyte recruitment to sites of inflammation. Members of a subgroup of chemokines, the CXC family, also play a critical role in both physiologic and pathologic angiogenesis, including in the context of chronic inflammation, fibrosis, and malignancy. A unique feature of this family of cytokines is that, on the basis of their structure and receptor binding, individual ligands display either angiogenic or angiostatic biological activity in the regulation of angiogenesis. In this review, we summarize the key literature in this growing field.
References
-
- Belperio JA, Keane MP, Arenberg DA, et al. CXC chemokines in angiogenesis. J Leukoc Biol. 2000;68:1–8. - PubMed
-
- Strieter RM, Polverini PJ, Kunkel SL, et al. The functional role of the ‘ELR’ motif in CXC chemokine-mediated angiogenesis. J Biol Chem. 1995;270:27348–27357. - PubMed
-
- Addison CL, Daniel TO, Burdick MD, et al. The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR(+) CXC chemokine-induced angiogenic activity. J Immunol. 2000;165:5269–5277. - PubMed
-
- Murdoch C, Monk PN, Finn A. Cxc Chemokine receptor expression on human endothelial cells. Cytokine. 1999;11:704–712. - PubMed
-
- Salcedo R, Resau JH, Halverson D, et al. Differential expression and responsiveness of chemokine receptors (CXCR1–3) by human microvascular endothelial cells and umbilical vein endothelial cells. Faseb J. 2000;14:2055–2064. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources